Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock

Shock

Volumn 34, Issue 3, 2010, Pages 275-280

  García Septien, Javier ^a,b,c   Lorente, José A ^a,b,c   Delgado, Miguel A ^b,c   De Paula, Marta ^a,b,c   Nin, Nicolás ^a,b,c   Moscoso, Amelia ^b   Sánchez Ferrer, Alberto ^a,b   Perez Vizcaino, Francisco ^a,d   Esteban, Andrés ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

hemodynamics; intramucosal acidosis; Levosimendan; sepsis; shock; tissue hypoxia

Indexed keywords

LEVOSIMENDAN; NORADRENALIN;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CARBON DIOXIDE TENSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; HEMODYNAMICS; HYPERKALEMIA; INTESTINE MUCOSA; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; NONHUMAN; OLIGURIA; PORTAL VEIN BLOOD FLOW; PULMONARY ARTERY CATHETER; SEPTIC SHOCK; SMALL INTESTINE; SPLANCHNIC BLOOD FLOW; SWINE; TISSUE OXYGENATION; TONOMETER; TREATMENT RESPONSE; VASOCONSTRICTION;

ACIDOSIS; ANIMALS; CARDIOTONIC AGENTS; CELL HYPOXIA; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI INFECTIONS; HEART RATE; HYDRAZONES; INTESTINAL MUCOSA; LIVER CIRCULATION; MICROCIRCULATION; MODELS, ANIMAL; PERITONITIS; PORTAL SYSTEM; PYRIDAZINES; SHOCK, SEPTIC; SWINE; VASODILATOR AGENTS;

EID: 77955948600     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cd8c5b     Document Type: Article

References (29)

1. Siegemund M, van Bommel J, Volbrecht K, Dries J, Ince C: Influence of NO donor SIN-1 on the gut oxygenation in a normodynamic porcine model of low-dose endotoxemia. Intensive Care Med 26:362, 2000.
2. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166: 98-104, 2002.
3. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27:1369-1377, 1999.
4. Buwalda M, Ince C: Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med 28:1208-1217, 2002.
5. Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D: Effects of levosimendan on right ventricular function in patients with advanced heart failure. Am J Cardiol 98: 1489-1492, 2006.
6. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N: The novel calcium sen-sitizer levosimendan activates the ATP sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther 283:375-383, 1997.
7. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M: Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 29:2185-2193, 2001.
8. Dubin A, Murias G, Sottile JP, Pozo MO, Barán M, Edul VS, Canales HS, Etcheverry G, Maskin B, Estenssoro E: Effects of levosimendan and dobuta-mine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 33:485-494, 2007.
9. Fries M, Ince C, Rossaint R, Bleilevens C, Bickenbach J, Rex S, Mik EG: Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit Care Med 36:1886-1891, 2008.
10. Schwarte LA, Picker O, Bernstein SR, Fournell A, Scheeren TW: Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Crit Care Med 33:246-247, 2005.
11. Taylor DE, Gutierrrez G, Clark C, Hainley S: Measurement of gastric muco-sal carbon dioxide tension by saline and air tonometry. J Crit Care 4:208-213, 1997.
12. VanderMeer TJ, Wang H, Fink MP: Endotoxemia causes ileal mucosal aci-dosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 7:1217-1226, 1995.
13. Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A: Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 35:1376-1382, 2007.
14. Hung J, Lew WY: Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res 73:125-134, 1993.
15. Goldhaber JI, Kim KH, Natterson PD, Lawrence T, Yang P, Weiss JN: Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 271:H1449-H1455, 1996.
16. Ming MJ, Hu DY, Chen HS, Liu LM, Nan X, Lu RQ: Effects of MCI-154, a calcium sensitizer, on cardiac dysfunction in endotoxic shock in rabbits. Shock 3:459-463, 2000.
17. Cunha-Goncalves D, Perez-de-Sa V, Dahm P, Grins E, Thorne J, Blomquist S: Cardiovascular effects of levosimendan in the early stages of endotoxemia. Shock 28:71-77, 2007.
18. Cogolludo A, Moreno L, Frazziano G, Moral-Sanz J, Menendez C, Castañeda J, González C, Villamor E, Perez-Vizcaino F: Activation of neutral sphingomy-elinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res 82:296-302, 2009.
19. Pagel PS, Hettrick DA, Warltier DC: Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 119:609-615, 1996.
20. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, et al.: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638-644, 2005.
21. Lorente JA, Landin L, Renes E, De Pablo R, Jorge P, Rodena E, Liste D: Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 5:759-767, 1993.
22. Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D: Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106:250-256, 1994.
23. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78:1051-1063, 1996.
24. Zingarelli B, Day JB, Crapo JD, Salzman AL, Szabo C: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endo-toxic shock. Br J Pharmacol 120:259-267, 1997.
25. Landry DW, Oliver JA: The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071-2074, 1992.
26. Vanelli G, Hussain SN, Aguggini G: Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig. Exp Physiol 80:167-170, 1995.
27. Czaika G, Gingras Y, Zhu E, Comtois AS: Induction of the ATP-sensitive potassium (uK(ATP)-1) channel by endotoxemia. Muscle Nerve 23:967-969, 2000.
28. Zhang H, Rogiers P, Smail N, Cabral A, Preiser JC, Peny MO, Vincent JL: Effects of nitric oxide on blood flow distribution and extraction capabilities during endotoxic shock. Am J Physiol 83:1164-1173, 1997.
29. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemand-van Straaten HM, Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360:1395-1396, 2002.